SHIPPING & SET-UP
Set-up
Tuesday May 14th 13:00 – 17:00
Wednesday May 15th 7:30 – 8:15
The Shipping & Collection Address
AstraZeneca R&D Molndal
MA1
Att: “ELRIG” in PGN
Pepparedsleden 3
431 53 Mölndal
Sweden
Contact phone to “Godsmottagningen” +46 76 502 34 48
Please mark all your boxes/goods clearly with your COMPANY NAME and YOUR STAND NUMBER
If you have several boxes/goods please mark them 1/3, 2/3, 3/3 etc..
Deliveries must arrive between May 9th and May 13th for set-up on May 14th 13:00 – 17:00 or May 15th before the conference open.
Your delivery will then be moved to a specific room in the PGN Conference Area “Lambda” by the AstraZeneca logistics Team.
This is close to the Exhibition Space. This room can also be used to store empty boxes during the conference.
Incoming goods – tracking
Unfortunately, we cannot check all incoming goods, therefore we kindly ask you to use your tracking number. If you have used the correct shipping address it will come to the right place.
Self-Drop off – If you plan to deliver directly to the conference centre then you can come between 13:00 and 17:00 on May 14th.
Restrictions (For Self Drop offs only)
Please note: the exhibition area is on the first floor. There is a broad staircase and a lift with a maximum width of 90
cm (door) x height of 230 cm and depth of 200 cm. there is a maximum load of 650 kg.
Please do not bring anything you may not be able to carry to the first floor by yourself i.e. no other lifting help is available .
Breakdown
Thursday May 16th 2024 14:30 – 17:00
Return shipping
Collections should be made after 12:00 on May 17th and before 12:00 May 20th
The Exhibitor are responsible for packing and labelling the goods/boxes for return shipment & order and pay for return pick of the goods.
ADVANCES IN CELL-BASED SCREENING IN DRUG DISCOVERY 2024
The fifth ELRIG meeting on Advances in Cell Based Screening in Drug Discovery will be held on May 15-16 at the AstraZeneca R&D site in Gothenburg. This interactive 2-day event will host leading scientists from academia, industry and the vendor community to discuss current and future formats for cell-based assays. Our ambition is to create an open and inspiring environment for networking between biologists and chemists, discussing the latest advancements and best practices in cell assay screening and their application for target identification, target validation and compound optimisation purposes.
Cell-based assays are utilised at all stages of drug discovery to explore disease mechanisms and to identify novel molecular therapeutics. To achieve this, the field is continuously looking for improvements in cell reagents, assay formats, and readouts to ensure disease-relevant contexts, aiming at improving translation to human physiology. Implementation of cell assays with more predictive translatability is much needed for improving success rates in drug discovery, and we are now entering an era where Artificial Intelligence and Machine Learning (AI/ML) can become the game changer. This meeting will explore how we continue to adapt to these challenges while working with unprecedented targets, novel biology, emerging drug modalities, the influence of international legislation and a drive for more sustainable drug discovery.
Track 1 – The power of the single cell – how microfluidics & OMICS enable a step change in data generation from individual cells.
Advancement in the ability to study single cells is intrinsically linked to parallel developments in microfluidic and omics technologies. Microfluidic devices enable precision control over cellular environments, while transcriptional, proteomic and metabolomic data provide comprehensive views across cellular components. The power of these technologies combined reveals intricate details about cellular processes, uncovers rare cell types and aims to understand the dynamics of biological systems at a single-cell resolution, impacting multiple fields of research where unmasking heterogeneity among cell populations plays a crucial role.
Track 2 – The promise of advanced cell models – the path to BAU, and the paradigm shift to NAMs (new approach methodologies/non-animal models) .
Understanding the landscape of emerging drug targets, candidate medicines and new modalities within a complex cellular environment is critical to modern research. Academics and industry scientists are increasingly turning to advanced preclinical models in order to identify and validate new biological hypotheses, as well as mitigate the risks of clinical efficacy- and safety-based attrition for new medicines. This session will highlight some of the most exciting preclinical model systems at the forefront of this wave of innovation.
Track 3 – Maximising outputs – how next-generation endpoints, and the use of biosensor are feeding a new wave of multiparametric data generation
A major challenge in drug discovery value chain is our current ability to predict in vivo efficacy and safety of candidate therapeutics. The use of advanced model systems, such as organoids, primary cell cultures, and multi-cellular spheroids, brings the promise of improved disease relevance and ability to recapitulate in vivo response to treatment. However, these come with a need to measure treatment response in multiple cell types and contexts. Next, generation endpoints address this need, providing new tools to quantify treatment response, monitor changes over time, and enable multiple endpoints from complex models. Advances in these techniques and methods are highlighted in this track including the use of multiparametric data and biosensors to capture complex cellular mechanisms.
Track 4 – New technologies – a look under the hood of new leading automation platforms and how they are revolutionising drug discovery
There is a constant need for developing drugs faster for treating human diseases and thus technology developers have for years invested in developing “The next big thing” that can support the need for efficiency in drug discovery. Automation in drug discovery, not only allows faster data generation, but contributes to better decision making based on consistent data and reducing the resources needed. Artificial Intelligence, machine learning, automation and robotics are only a few examples of technologies that can accelerate and transform drug discovery processes. This session will introduce a few examples of novel technologies and automation.
CONFERENCE DIRECTORS
Fredrik Edfeldt – AstraZeneca
Sapna Desai – GSK
Sam Barichievy – AstraZeneca
James Robinson – AstraZeneca
Brinton Seashore-Ludlow – Karolinska Institutet
The meeting program is developed around two themes with four key focus areas (tracks):
The journey of scale: from single cells to complex models (theme for day 1)
Track 1: The power of the single cell – how microfluidics & OMICS enable a step change in data generation from individual cells
Advancement in the ability to study single cells is intrinsically linked to parallel developments in microfluidic and omics technologies. Microfluidic devices enable precision control over cellular environments, while transcriptional, proteomic and metabolomic data provide comprehensive views across cellular components. The power of these technologies combined reveals intricate details about cellular processes, uncovers rare cell types and aims to understand the dynamics of biological systems at a single-cell resolution, impacting multiple fields of research where unmasking heterogeneity among cell populations plays a crucial role.
Track 2: The promise of advanced cell models – the path to BAU, and the paradigm shift to NAMs (new approach methodologies/non-animal models)
Understanding the landscape of emerging drug targets, candidate medicines and new modalities within a complex cellular environment is critical to modern research. Academics and industry scientists are increasingly turning to advanced preclinical models in order to identify and validate new biological hypotheses, as well as mitigate the risks of clinical efficacy- and safety-based attrition for new medicines. This session will highlight some of the most exciting preclinical model systems at the forefront of this wave of innovation.
The journey of translation: improving end-points and adding texture in cell-based screens (theme for day 2)
Track 3: Maximising outputs – how next-generation endpoints, and the use of biosensors are feeding a new wave of multifactorial data generation
A major challenge in drug discovery value chain is our current ability to predict in vivo efficacy and safety of candidate therapeutics. The use of advanced model systems, such as organoids, primary cell cultures, and multi-cellular spheroids, brings the promise of improved disease relevance and ability to recapitulate in vivo response to treatment. However, these come with a need to measure treatment response in multiple cell types and contexts. Next, generation endpoints address this need, providing new tools to quantify treatment response, monitor changes over time, and enable multiple endpoints from complex models. Advances in these techniques and methods are highlighted in this track including the use of multiparametric data and biosensors to capture complex cellular mechanisms.
Track 4: New Technologies – a look under the hood of new leading technological platforms and how they are revolutionising drug discovery
POSTER SUBMISSION AT ELRIG EVENTS
Exhibitors must follow the procedure below. A poster at the event is not guaranteed
To submit a poster application for Advances in Cell-Based Screening in Drug Discovery 2024, you must first register for the event. Registration is possible via the Exhibitor Portal link. A link to the poster portal will be available in your registration confirmation email.
PLEASE NOTE: We have limited capacity for posters on site and they will be accepted on a first come first served basis, When capacity is reached a holding list will be opened and you will be notified if spaces become available.
Poster Deadlines:
To be considered for a flash presentation at Advances in Cell-Based Screening in Drug Discovery 2024 please submit your title and abstract by 15 April 2024. The deadline for other posters is 28 April 2024
Poster Acceptance:
The author will be held responsible for false statements, the scientific judging panel will ensure the poster is relevant to the event content. Successful poster applications will be notified via email and the poster display number will be given approximately two weeks before the event.
During the event:
A board will be available with your poster number and Velcro strips to affix your poster (your poster must be A0 portrait).
Poster sessions will take place for 30-minute in the networking session at the end of Day 1 and for 30 mins during the lunchbreak on Day 2. You will be expended to be at your poster during these times to answer questions from delegates.
A Poster Prize will be awarded for Best Early Career Professional Poster, the posters will be judged (you will not need to be at your poster during judging) and the prize awarded during the event.
The prize is a glass trophy and £250, which can be accepted, donated to your lab or donated to a charity of your choice.
All posters will need to be collected at the end of the event and removed from site; any posters left at the end of the event will be disposed of.
Flash Poster presentations:
This is an opportunity to showcase your poster in a Flash presentation to the ELRIG community, if your poster is chosen you will need to prepare a PowerPoint presentation and you will be given presentation timings. The scientific judging panel will review the posters submitted for Flash poster presentations and if successful you will receive confirmation from the ELRIG Team two weeks prior to the event.
If you have any questions about posters please email us at events@elrig.org – Thank you
Venue & Directions
Conference Venue
AstraZeneca
PGN entrance
Pepparedsleden 5
431 53 Mölndal
Accommodation
Discounted Accommodation for Advances in Cell-Based Screening in Drug Discovery 2024 will be available at the Quality Hotel the Weaver. A link will appear here closer to the event.
Quality Hotel
Göteborgsvägen 91
431 37 Mölndal
ELRIG is only able to provide suggestions on how delegates may travel to or places they may stay at, to attend its events. However, ELRIG cannot recommend nor endorse any of the travel choices nor hotels that attendees make and is not liable for any of the services that its delegates procure.
Social Media
Download our useful social media images to share that you’ll be attending Advances in Cell-Based Screening in Drug Discovery 2024 with your network.
Please add ELRIG to your posts. #CBS2024 #ELRIG
What is included with a standard booth.
- 1.8m x 0.7m table
- Two chairs
- Electrical socket
- The Lead capture function is available through the ELRIG App and is only available for those registered as Exhibitor staff
- Complimentary refreshments and lunch
- Networking Session May 15th 17:00-19:00
Vendor Talks
ELRIG encourages exhibitors to purchase talk time within the main podium programme to maximise their presence at a meeting, but you may only purchase talk time if you have purchased a booth. The different talks available are:
Technology Spotlight Partner: The most cost-effective way to drive traffic to your booth is by adding a 5-minute
Technology Spotlight presentation. This podium presentation is part of the published programme and takes place
before the entire conference audience. Technology Spotlight presentations focus on a specific product or service.
Industry Insider Partner: This package includes a 15-minute podium presentation within the main programme and is
designed to position you as an industry influencer. The presentation’s length will allow you to introduce your company,
describe a specific offering and present a single case study to reinforce your message. It is required that the talk topic
be relevant to the main theme of the programme.
Conference Partner: This provides an opportunity for you to present your latest news, technology, or product update to
the entire audience at an ELRIG event. The presentation length is equivalent to an invited podium presentation, therefore
it is essential that the content be aligned to the track theme, explaining the need and science behind the innovation whilst
not being overtly commercial. The presentation may end with a pointer towards product availability and the vendor’s
Partner’s booth.
Exhibitor staff Tickets
Each booth comes with 2 exhibitor staff tickets. These allow access to the talks.
Additional tickets will be charged at £50 per ticket for the duration of the conference.
Registration List
The GDPR compliant registration list will be sent on May 1st 2024
The GDPR compliant attendee list and final registration list will be sent on May 17th 2024
Lead Capture Device
The lead capture function is available through the ELRIG app and is only available to those registered as an exhibitor.
Questions within the function can be set by the Booth Manager via the Exhibitor Portal.
The Exhibitor Portal is the location for stored leads and the download post event
Exhibitor-Lead-Management-in-EventsAir Guide
Social Media
View the resources tab for a graphic to share.
Please add ELRIG to your posts. #CBS2024 #ELRIG
Before you attend Advances In Cell-Based Screening In Drug Discovery 2024
No later than 10 days before
- Send a high-resolution copy of your logo.
- Confirm the company name you wish to exhibit under.
- Register your exhibitor staff via the Exhibitor Portal.
- Ask your staff to download the ELRIG app.
No later than 7 days before
- Ensure that payment for the event is made at least 7 days before you arrive to set-up.
- Send your insurance Certificate to events@elrig.org. You must have Public and Employee Liability Insurance of at Least £1m.
If you have an issue with the any of the above actions, please contact
Tara Shanks
EVENTS MANAGER
tara.shanks@elrig.org
+44 (0) 7484 113971
Our App
ALL OUR EVENT INFORMATION IN
THE PALM OF YOUR HAND
If you plan to attend an ELRIG event download the free ELRIG app and access all our conference information and lecture schedules and more straight from your phone or pad..